社区获得性肺炎合并肺栓塞的临床特征初步研究
该回顾性研究纳入39例社区获得性肺炎(CAP)合并急性肺栓塞患者与78例单纯CAP患者,按性别年龄1∶2匹配。结果显示合并肺栓塞组呼吸困难、心脏病史、风湿免疫病史更常见,D-二聚体、动脉血pH、BNP及下肢静脉血栓发生率更高,PaCO2更低;logistic回归提示D-二聚体和呼吸困难与肺栓塞风险相关。
要点
- CAP患者出现呼吸困难、心脏病史或风湿免疫病史时应警惕合并急性肺栓塞。
- D-二聚体、动脉血pH、PaCO2、BNP及下肢静脉彩超对诊断有提示作用。
- D-二聚体和呼吸困难与CAP合并肺栓塞风险相关。
核心结论
- CAP患者出现呼吸困难或有心脏病史、风湿免疫系统疾病史时,应考虑急性肺栓塞的鉴别诊断。
- 血D-二聚体、动脉血pH值、PaCO2、BNP测定及下肢静脉彩超对肺炎合并急性肺栓塞有提示作用。
研究设计与样本
- 回顾性分析北京大学人民医院2012年1月至2017年12月住院的CAP合并急性肺栓塞患者39例(A组)。
- 按性别、年龄1∶2匹配收集同期住院单纯CAP患者78例(B组),比较两组临床资料。
- 统计方法采用配对资料卡方检验、秩和检验及logistic回归分析。
主要发现
- A组呼吸困难发生率21/39,高于B组21/78(P=0.004)。
- A组心脏病史10/39高于B组8/78(P=0.031),风湿免疫系统疾病史3/39高于B组0/78(P=0.035)。
- A组D-二聚体2 222(854,3 539)ng/ml高于B组295(168,707)ng/ml(P<0.001)。
- A组动脉血pH 7.5±0.5高于B组7.4±0.4(P=0.022),BNP 103.9(48.7,236.8)pg/ml高于B组98.4(44.8,246.3)pg/ml(P=0.028)。
- A组下肢静脉血栓发生率18/39高于B组3/41(P<0.001),PaCO2(35.3±6.2)mmHg低于B组(38.4±4.4)mmHg(P=0.009)。
关键数值与推荐
- logistic回归分析显示D-二聚体(P=0.000)和呼吸困难(P=0.033)与CAP合并肺栓塞风险相关。
临床怎么用
- 对CAP患者应询问心脏病史及风湿免疫系统疾病史,并关注呼吸困难表现。
- 对疑似患者可检测D-二聚体、动脉血pH、PaCO2、BNP并进行下肢静脉彩超检查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To understanding the clinical characteristics of the patients of pneumonia concomitant with acute pulmonary embolism, and the early identification of high-risk patients. Methods: Retrospective analysis of hospitalized patients with confirmed diagnosis of community acquired pneumonia (CAP) with concomitant pulmonary embolism (PE) within a period of 5 years. Patients hospitalized with CAP alone in the same period were included in the control group in a ratio of 1∶2 according to the principle of gender and age. The demographic characteristics, clinical feature, laboratory examination, radiographic and other clinical data of these 2 groups of patients were studied. Statistical analysis was performed by Chi-square test, Kruskal-Wallis test and logistic regression. Results: Thirty-nine patients with CAP combined with PE and 78 patients with CAP alone were included. Compared to patients with CAP alone, dyspnea (21/39 vs 21/78, P=0.004), a history of heart disease (10/39 vs 8/78, P=0.031), and a history of connective tissue diseases (3/39 vs 0/78, P=0.035) were more common to seen in patients with CAP combined with PE. D-dimer [2 222(854, 3 539) ng/ml vs 295(168, 707) ng/ml, P=0.000], arterial PH value (7.5±0.5 vs 7.4±0.4, P=0.022), BNP [103.9(48.7, 236.8) pg/ml vs 98.4(44.8, 246.3) pg/ml, P=0.028] and incidence of lower extremity venous thrombosis (18/39 vs 3/41, P=0.000) were higher in patients with CAP combined with PE, while arterial partial pressure of CO2 [(35.3±6.2) mmHg vs (38.4±4.4) mmHg, P=0.009, 1 mmHg=0.133 kPa] was lower. Logistic regression analysis showed that D-dimer (P=0.000) and dyspnea (P=0.033) were associated with the risk of PE. Conclusion: When patients with CAP represent dyspnea or have a history of heart disease or connective tissue diseases concomitant PE should be considered for differential diagnosis. Determination of D-dimer, arterial PH value, arterial partial pressure of CO2, BNP and ultrasonography of lower extremities had important implications for the diagnosis of pneumonia complicated with acute pulmonary embolism. 目的: 了解社区获得性肺炎(CAP)合并急性肺栓塞患者的临床特征,有助于及早识别高危患者。 方法: 回顾性收集北京大学人民医院2012年1月至2017年12月住院治疗的明确诊断CAP合并急性肺栓塞的患者39例(A组),按照性别、年龄匹配的原则以1∶2的比例收集同期住院治疗的单纯社区获得性肺炎患者78例(B组)。分析两组患者的人口学特征、发病时间、临床特点、实验室检查及胸部影像学等临床资料。应用配对资料的卡方检验、秩和检验及logistic回归分析进行对比分析。 结果: A组患者呼吸困难发生率为21/39,高于B组(21/78),差异有统计学意义(P=0.004)。A组合并心脏病史发生率为10/39,风湿免疫系统疾病史发生率为3/39,均高于B组(8/78,P=0.031;0/78,P=0.035)。A组D-二聚体为2 222(854,3 539) ng/ml,动脉血pH值为7.5±0.5,B型钠尿肽为103.9(48.7,236.8) pg/ml,下肢静脉血栓发生率为18/39,均高于B组[295(168,707)ng/ml,P<0.001;7.4±0.4,P=0.022;98.4(44.8,246.3) pg/ml,P=0.028;3/41,P<0.001],A组PaCO2为(35.3±6.2) mmHg(1 mmHg=0.133 kPa),低于B组[(38.4±4.4) mmHg,P=0.009]。logistic回归分析结果显示D-二聚体(P=0.000)和呼吸困难(P=0.033)与CAP合并肺栓塞风险相关。 结论: 对合并呼吸困难的CAP患者,以及合并心脏病史或风湿免疫系统疾病史的患者,应警惕急性肺栓塞。血D-二聚体、动脉血pH值、PaCO2、B型钠尿肽测定以及下肢静脉彩超检查对肺炎合并急性肺栓塞有提示作用。.
引用
- Wang F, Chen X, Gai J, et al. [A preliminary investigation of the clinical characteristics of community acquired pneumonia with concomitant pulmonary embolism]. Zhonghua Jie He He Hu Xi Za Zhi. 2021. PMID: 34102713. doi:10.3760/cma.j.cn112147-20210329-00208
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。